View Document Preview and Link Document Date: 2011-02-03 06:45:28 Open Document File Size: 859,84 KB Share Result on Facebook
City York / Athens / / Company ACE / / Continent Europe / / Country Japan / United States / Canada / Sweden / Greece / South Africa / / / Facility Insurance Institute / / IndustryTerm pharmaceuticals / treatment of hypertension / literature search / / MedicalCondition concomitant diabetes / mild-to-moderate hypertension / strokes / hypertension / primary hypertension / disease / left ventricular hypertrophy / Non-Insulin-Dependent Diabetes Mellitus / ESRD / essential hypertension / stroke / diabetes / cerebrovascular disease / cardiovascular disease / e.g. heart failure / myocardial infarction / heart failure / diseases / several cardiovascular diseases / myocardial infarctions / coronary heart disease / end-stage renal disease / LVH / uncontrolled mild-to-moderate uncomplicated hypertension / / MedicalTreatment dialysis / renal transplant / / Organization World Health Organisation / Centre for Reviews and Dissemination / Office for Health Economics / National School of Public Health / 3Social Insurance Institute / Nikos Maniadakis Health Services Organisation / 2Health Services Organisation / NHS / 4York University / / Person Nikos Maniadakis / / Position experienced researcher / / Product telmisartan / valsartan / irbesartan / chlorthalidone / nifedipine / atenolol / losartan / hydrochlorothiazide / / PublishedMedium Health Economics / / Technology dialysis / / SocialTag 
Hellenic J Cardiol 2009; 50: [removed]Original Research